Table 1.
Distribution of subjects in the cohort by age at first test, sex, duration of follow-up, cancer frequency, and frequency of CAs.
Median (25th–75th percentiles)
|
||||||||
---|---|---|---|---|---|---|---|---|
Occupational exposure | No. of subjects | Mean age at first test (years) | Sex (% males) | Mean years since test | Cancer cases (%) | CAs | CTAs | CSAs |
Ionizing radiation | 676 | 40.3 | 70.4 | 11.6 | 57 (8.4) | 2.5 (1.5–4.0) | 2.0 (1.0–3.0) | 1.0 (0.0–2.0) |
Cytostatic drugs | 2,150 | 36.5 | 12.8 | 7.4 | 61 (2.8) | 2.0 (1.0–3.0) | 1.3 (1.0–2.0) | 0.0 (0.0–1.0) |
Polyclic aromatic hydrocarbons | 2,241 | 39.4 | 86.1 | 10.1 | 108 (4.8) | 2.0 (1.0–3.5) | 1.5 (1.0–2.4) | 1.0 (0.0–1.0) |
Aromatic amines | 851 | 40.3 | 57.8 | 9.0 | 28 (3.3) | 2.0 (1.3–3.0) | 1.8 (1.0–3.0) | 0.6 (0.0–1.0) |
Other exposures | 4,031 | 38.0 | 58.7 | 10.7 | 170 (4.2) | 2.0 (1.0–3.0) | 1.0 (1.0–2.0) | 0.5 (0.0–1.0) |
Nonexposed | 1,913 | 36.2 | 55.2 | 8.8 | 61 (3.2) | 2.0 (1.0–3.0) | 1.0 (0.5–2.0) | 0.0 (0.0–1.0) |
Total cohort | 11,862 | 38.0 | 55.6 | 9.6 | 485 (4.1) | 2.0 (1.0–3.0) | 1.0 (1.0–2.0) | 0.5 (0.0–1.0) |